SANSHO Co., Ltd. is a biotech venture company operating in three business areas: pharmaceuticals, cosmetics, and food, leveraging its core technology of cyclic phosphatidic acid (cPA), a result of research at Ochanomizu University.
In its core pharmaceutical business, SANSHO is building multiple pipelines by leveraging cPA's unique mechanisms of action, including anti-inflammatory, tissue regenerative, and anti-fibrotic properties. One such pipeline, SSO-001, is a new compound with the potential to promote cartilage regeneration and is currently progressing smoothly in clinical trials overseas.
Other pipelines in the development stage include SSI-002, a drug for idiopathic pulmonary fibrosis, and SSG-003, a drug for glaucoma.
SANSHO also sells cPA as a cosmetic and food ingredient. The products developed using technology cultivated through pharmaceutical development have received a certain level of recognition in the market, and the company is working to further expand its business.

SANSHO Co., Ltd.

Org chart

Teams

Offices

SANSHO Co., Ltd.

Org chart

Teams

Offices

Related companies